Significant Price Hike: 14 Essential Medicines See 250% Increase

The pharmaceutical sector in Pakistan is witnessing a substantial price surge, with 14 essential medicines experiencing up to a 250% increase.

Medicines Affected

The affected medicines include treatments for common ailments such as hypertension, diabetes, and bacterial infections. This sharp rise has raised concerns among healthcare professionals and the general public about the affordability and accessibility of crucial medications.

Factors Contributing to the Increase

Industry experts attribute this hike to several factors:

• Currency Depreciation: The devaluation of the Pakistani rupee has increased import costs for raw materials.
• Inflation: Overall economic inflation has escalated production and distribution expenses.
• Regulatory Adjustments: Recent policy changes have allowed pharmaceutical companies to revise prices to maintain profitability.

Impact on Public Health

The price escalation poses a significant challenge to patients, particularly those from low-income backgrounds, potentially leading to decreased adherence to treatment regimens and adverse health outcomes.

Government’s Response

Health authorities are reportedly reviewing the situation to balance the interests of pharmaceutical companies and public health needs, aiming to ensure that essential medicines remain accessible to all segments of society.